Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

546 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Breast cancer in pregnancy: recommendations of an international consensus meeting.
Amant F, Deckers S, Van Calsteren K, Loibl S, Halaska M, Brepoels L, Beijnen J, Cardoso F, Gentilini O, Lagae L, Mir O, Neven P, Ottevanger N, Pans S, Peccatori F, Rouzier R, Senn HJ, Struikmans H, Christiaens MR, Cameron D, Du Bois A. Amant F, et al. Among authors: neven p. Eur J Cancer. 2010 Dec;46(18):3158-68. doi: 10.1016/j.ejca.2010.09.010. Eur J Cancer. 2010. PMID: 20932740
Additional value of PET-CT in staging of clinical stage IIB and III breast cancer.
Segaert I, Mottaghy F, Ceyssens S, De Wever W, Stroobants S, Van Ongeval C, Van Limbergen E, Wildiers H, Paridaens R, Vergote I, Christiaens MR, Neven P. Segaert I, et al. Among authors: neven p. Breast J. 2010 Nov-Dec;16(6):617-24. doi: 10.1111/j.1524-4741.2010.00987.x. Breast J. 2010. PMID: 21070439
Drug safety evaluation of exemestane.
Lintermans A, Neven P, Paridaens R. Lintermans A, et al. Among authors: neven p. Expert Opin Drug Saf. 2011 May;10(3):473-87. doi: 10.1517/14740338.2011.567264. Epub 2011 Mar 24. Expert Opin Drug Saf. 2011. PMID: 21428848 Review.
Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.
Regan MM, Neven P, Giobbie-Hurder A, Goldhirsch A, Ejlertsen B, Mauriac L, Forbes JF, Smith I, Láng I, Wardley A, Rabaglio M, Price KN, Gelber RD, Coates AS, Thürlimann B; BIG 1-98 Collaborative Group; International Breast Cancer Study Group (IBCSG). Regan MM, et al. Among authors: neven p. Lancet Oncol. 2011 Nov;12(12):1101-8. doi: 10.1016/S1470-2045(11)70270-4. Epub 2011 Oct 20. Lancet Oncol. 2011. PMID: 22018631 Free PMC article. Clinical Trial.
Adjuvant trastuzumab in HER2-positive breast cancer.
Vanderhaegen J, Paridaens R, Neven P. Vanderhaegen J, et al. Among authors: neven p. N Engl J Med. 2012 Feb 16;366(7):664; author reply 664-6. doi: 10.1056/NEJMc1112823. N Engl J Med. 2012. PMID: 22335750 No abstract available.
546 results